SCHEMBL14009116

SCHEMBL14009116

O=C(NCc1ccccc1)c1ccc(C(=O)Nc2ccc(-n3cncn3)cc2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 2/20 0.47
▸ HDAC4 P56524 2/20 0.47
▸ HDAC1 Q13547 2/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47
▸ ROCK2 O75116 2/20 0.47
▸ ROCK1 Q13464 2/20 0.47
▸ MIF P14174 1/20 0.47
▸ ESRRG P62508 1/20 0.43
▸ TP53 P04637 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ DHODH Q02127 2/20 0.41
▸ HDAC7 Q8WUI4 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC10 Q969S8 1/20 0.41
▸ HDAC11 Q96DB2 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC9 Q9UKV0 1/20 0.41
▸ HDAC5 Q9UQL6 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009170 0.92 ROCK2 (0.43) ROCK2ROCK1NAMPTFLT1KDR
SCHEMBL14009134 0.90 MEN1 (0.49) ROCK2DHODHMEN1KMT2ANAMPT
SCHEMBL14009139 0.90 HDAC1 (0.49) HDAC3HDAC4HDAC1HDAC6ROCK2
SCHEMBL14009163 0.89 ROCK1 (0.51) HDAC3HDAC4HDAC1HDAC6ROCK1
SCHEMBL14009123 0.87 HPGD (0.52) ROCK1MEN1NPC1KMT2ANAMPT
SCHEMBL14009218 0.85 NPC1 (0.46) ROCK2ROCK1TP53MAPTMEN1
SCHEMBL14009214 0.84 HDAC1 (0.41) HDAC1ROCK2ROCK1TP53NPC1
SCHEMBL14009349 0.84 ROCK1 (0.46) ROCK1TP53MAPTMEN1NPC1
SCHEMBL14009149 0.83 HDAC3 (0.47) HDAC3HDAC4HDAC1HDAC6ROCK2
SCHEMBL14009094 0.83 ROCK1 (0.42) ROCK2ROCK1MAPTNPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
WO-2007022258-A1 NOVEL HIGH AFFINITY THIOPHENE-BASED AND FURAN-BASED KINASE LIGANDS SCHERING CORPORATION (US) 2007-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands CDKL2, CDK2, CDKL1 HDAC3 2248/4885HDAC4 1484/4885HDAC1 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback